Blog

Anirban Maitra: Timely video on diet impacting your gut microbiome in a good way

Photo of Anirban Maitra from faculty.mdanderson.org

Jul 11, 2024, 03:47

Anirban Maitra: Timely video on diet impacting your gut microbiome in a good way

Anirban Maitra shared a post by Patrick Hwu, on X:

“Timely video on diet impacting your gut microbiome in a good way, from Patrick Hwu who knows how to kick those Blastocystis counts way up. From Cell this morning.”

Anirban Maitra

Quoting Patrick Hwu‘s post:

“Have you tried chia pudding? It’s a great way to increase the fiber in your diet to fuel a healthy microbiome!
Here’s how to make it!”

Read further.
Source: Anirban Maitra/X and Patrick Hwu/X

Dr. Anriban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center.

He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.

Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy. He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.